September 28, 2009 Issue | Chemical & Engineering News
 
 

C&EN congratulates Dan Fagin on winning the 2014 Pulitzer Prize in General Nonfiction for “Toms River: A Story of Science and Salvation” (Bantam Books). C&EN’s Rudy Baum reviewed “Toms River” last May.

 
Copyright © 2009 American Chemical Society
 

September 28, 2009 Issue

Volume 87, Issue 39
8739cov1_stockingup
September 28, 2009 Issue, Vol. 87 | Iss. 39
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
By Ann M. Thayer
(pp. 15-26)
Features
Business
Investment flows into the U.S. as drugmakers reassess their supply chains (pp. 38-41)
Science & Technology
Advances in breeding and basic science confer drought tolerance to crops (pp. 60-62)
Back Issues
 

Cover Story: Flu Fighters

Flu Vaccine Race Against The Clock
Developers have made vaccines against the pandemic flu but now must deliver them in time
(pp. 27-33)
 

News of the Week

Moon's Surface Holds Water

Planetary Science: Spectral results from three different spacecraft confirm presence of H2O or HO
(p.9)

Progress, But No Breakthroughs

Climate-Change Summit: U.S., China endorse Copenhagen talks
(p.10)

Solar Cells Get Chemistry Help

Photovoltaics: Chemical makers see efficiency opportunity
(p.10)

Biotech Stocks

Falling share prices could lead to market delisting for many firms
(p.11)

Data Manipulation At ETH

Misconduct: Fabricated chemistry data at Switzerland's premier research institution leads to resignation
(p.11)

Heads Butt Over Deadly Explosion

Dust Accident: Safety board seeks better maintenance; unions want tougher regulations
(p.12)

Unusual Aluminum Bonding Geometry

Catalysis: Pentacoordinated Al joins Pt in supported catalysts
(p.12)

Mass Spec As A Surgical Tool

Clinical Chemistry: Analytical technique can help distinguish cancerous from healthy tissue
(p.13)

Unearthing Nature's Bounty

Chemical Biology: Mass spectrometry anchors tactic for finding new natural products from microbes
(p.13)
 

Departments

8739bus1_safc

Business

Investment flows into the U.S. as drugmakers reassess their supply chains
(pp. 38-41)
Small-molecule drugs to treat dry age-related macular degeneration are heading to the clinic
(pp. 43-45)
Colleagues, puzzled by charges, wonder whether it is all a misunderstanding
(pp. 47-48)
Developers have made vaccines against the pandemic flu but now must deliver them in time
(pp. 27-33)
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
(pp. 15-26)

ACS News

Governance bodies receive reports, debate election procedure
(pp. 70-72)
8739gov2_spitkit

Government & Policy

Makers of brand-name biologics get closer to winning 12 years of exclusivity before generic versions can come to market
(pp. 51-53)
Direct-to-consumer companies are proliferating, raising questions about quality and lack of standards
(pp. 54-57)
8739cov1_box

Science & Technology

Advances in breeding and basic science confer drought tolerance to crops
(pp. 60-62)
Unique challenges face developers of drugs that hit disease-related RNAs rather than disease-related proteins
(pp. 63-66)
Technology and Business news for the laboratory world
(p.68)

Editor's Page